Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-25-007769
Filing Date
2025-06-13
Accepted
2025-06-13 16:42:46
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 HUNTER - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP hunter-form4.html 4  
1 HUNTER - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP hunter-form4.xml 4 4106
2 POWER OF ATTORNEY ex24.htm EX-24 6226
  Complete submission text file 0001999371-25-007769.txt   11892
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address
Hunter James Randolph Jr (Reporting) CIK: 0002071788 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 251047273